Cargando…

Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma

TP63 encodes TAp63, which is functionally similar to the tumor suppressor TP53, and ΔNp63, which lacks the transcription-activating domain of TAp63 and appears potently oncogenic in squamous cell carcinomas (SCCs). In this study, we developed an integrated CRISPR interference (CRISPRi) system to sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Masakazu, Yokota, Etsuko, Sakuma, Tetsushi, Yamatsuji, Tomoki, Takigawa, Nagio, Ushijima, Toshikazu, Yamamoto, Takashi, Fukazawa, Takuya, Naomoto, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044376/
https://www.ncbi.nlm.nih.gov/pubmed/30018747
http://dx.doi.org/10.18632/oncotarget.25678

Ejemplares similares